Study ties diabetes, obesity to higher risk of cancer recurrence

08/14/2013 | MedWire News (U.K.)

A study in the Japanese Journal of Clinical Oncology revealed patients with renal cell carcinoma and type 2 diabetes were more than twice as likely to experience cancer recurrence than those without diabetes. Researchers also found obese RCC patients had more than a fourfold increased risk of recurrence compared with nonobese patients. Obese patients with diabetes also showed a lower five-year recurrence-free survival rate of 75.3%, compared with 91.9% in those without diabetes, researchers said.

View Full Article in:

MedWire News (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN